Thailand Advances Cannabis Recriminalization With New Industry Restrictions

Cabinet approves sweeping restrictions on cannabis commerce and cultivation

Thailand's cabinet approved new cannabis control measures on September 22, 2026, according to The Business Times. The regulations ban recreational cannabis sales and impose mandatory licensing on medical and industrial operators. It's the most direct reversal yet of the June 2022 decriminalization that removed cannabis from Thailand's Category 5 narcotics list.

All cannabis retailers must now obtain medical dispensary licenses. Cultivation permits will be limited to operators demonstrating medical or industrial use cases. Recreational storefronts, which proliferated across Bangkok and tourist districts following decriminalization, face closure under the updated rules.

Policy shift follows two years of regulatory uncertainty

Thailand decriminalized cannabis in June 2022 under the Prayut Chan-o-cha government, removing the plant from Schedule 5 of the Narcotics Act. But the policy created a legal gray zone: cultivation and possession were permitted, yet no retail framework was codified. Thousands of cannabis shops opened without clear licensing standards.

The Srettha Thavisin administration, which took office in August 2023, pledged to re-regulate the sector. Draft legislation introduced in early 2026 proposed reclassifying cannabis as a controlled substance with medical-only access. The September 22 cabinet action implements administrative restrictions ahead of pending parliamentary votes on full recriminalization.

Licensing requirements target medical and industrial operators

Cannabis businesses must apply for one of two license categories: medical dispensary or industrial processor. Medical licenses require a licensed pharmacist on staff and limit sales to patients with prescriptions. Industrial licenses cover hemp-derived CBD extraction and textile production, with THC content capped at 0.2 percent by dry weight.

Existing retailers have 90 days to apply for medical dispensary licenses or cease operations. The Public Health Ministry will oversee the licensing process. Operators failing to comply face fines up to 100,000 baht and potential criminal charges under the Narcotics Act.

Recreational market faces shutdown as enforcement begins

Thailand's recreational cannabis market grew to an estimated $1.2 billion in annual sales by mid-2026, with over 6,000 registered dispensaries. The new restrictions effectively ban this segment. Shops selling cannabis for non-medical use must close or pivot to licensed medical models.

Enforcement authority rests with the Food and Drug Administration and local police. Raids on unlicensed retailers began in select Bangkok districts in early September, ahead of the cabinet vote. Industry groups estimate 70 percent of current operators lack the capital or pharmacist access to qualify for medical licenses.

Parliamentary vote on full recriminalization expected in Q4 2026

The cabinet's administrative actions precede a legislative push to reclassify cannabis as a Category 5 narcotic. A draft bill sponsored by the Public Health Ministry is scheduled for first reading in Thailand's House of Representatives in November 2026. If passed, the law would restore criminal penalties for unlicensed possession and cultivation.

Exemptions for medical patients and licensed industrial operators are written into the bill. Personal cultivation of up to six plants for medical use would remain legal with a permit. Recreational possession of any quantity would become a criminal offense punishable by up to one year in prison.

Regional implications as Southeast Asia watches Thailand's reversal

Thailand's policy reversal carries weight across Southeast Asia, where most nations maintain strict cannabis prohibitions. Malaysia and the Philippines have cited Thailand's decriminalization experiment as a cautionary case in domestic drug-policy debates. Singapore, which maintains capital punishment for drug trafficking, has publicly criticized Thailand's 2022 liberalization.

For full background on this story, see the CannIntel topic hub on Thailand Cannabis Recriminalization. The next signal: parliamentary committee hearings on the recriminalization bill are scheduled for mid-October 2026. Industry observers will watch whether amendments preserve broader medical access or tighten restrictions further.